1190002F15Rik activators are a diverse cohort of chemical compounds that enhance the protein's functionality by modulating various cellular signaling cascades. Forskolin, through the elevation of cAMP levels, activates PKA, which may phosphorylate proteins that engage with 1190002F15Rik, leading to its activation. Similarly, the antioxidant properties of Epigallocatechin gallate inhibit kinases that may be responsible for repressive phosphorylation of 1190002F15Rik, thus preventing inhibition and promoting activation. The lipid signaling molecule Sphingosine-1-phosphate activates intracellular pathways, such as those mediated by PI3K/Akt, which could have downstream effects that enhance 1190002F15Rik activity, assuming the protein is part of or influenced by this pathway. PMA, acting as a PKC activator, might alter phosphorylation states of proteins associated with 1190002F15Rik, thereby enhancing its activity. Inhibitors of cellular kinases and phosphatases like LY294002, U0126, and SB203580 uniquely modulate signaling equilibrium, potentially shifting the balance toward activation of 1190002F15Rik. A23187, as a calcium ionophore, raises intracellular calcium and activates calcium-dependent signaling pathways, possibly amplifying 1190002F15Rik activity if it is modulated by such signaling.
The kinase inhibitor Genistein could also potentiate 1190002F15Rik activity by reducing competitive tyrosine kinase phosphorylation, allowing for more active 1190002F15Rik pathways. In contrast, Staurosporine, despite being a broad-spectrum kinase inhibitor, could selectively enhance 1190002F15Rik activity by inhibiting kinases that exert negative control over it. Wortmannin, akin to LY294002, inhibits PI3K, which might relieve 1190002F15Rik from any PI3K-mediated repression, thus facilitating its activation. The collective actions of these activators, through specific and targeted effects on cellular signaling pathways, enable the upregulation of 1190002F15Rik's functional activity. This concerted modulation of signal transduction pathways by these chemical activators ensures the amplification of 1190002F15Rik's biological role without necessitating changes in its expression levels or direct protein interaction.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
(−)-Epigallocatechin Gallate | 989-51-5 | sc-200802 sc-200802A sc-200802B sc-200802C sc-200802D sc-200802E | 10 mg 50 mg 100 mg 500 mg 1 g 10 g | $43.00 $73.00 $126.00 $243.00 $530.00 $1259.00 | 11 | |
Epigallocatechin gallate is a potent antioxidant that inhibits several protein kinases. By inhibiting these kinases, it may prevent phosphorylation-based inhibition of 1190002F15Rik, thus enhancing its activity if 1190002F15Rik is regulated by such inhibitory phosphorylation events. | ||||||
D-erythro-Sphingosine-1-phosphate | 26993-30-6 | sc-201383 sc-201383D sc-201383A sc-201383B sc-201383C | 1 mg 2 mg 5 mg 10 mg 25 mg | $165.00 $322.00 $570.00 $907.00 $1727.00 | 7 | |
Sphingosine-1-phosphate acts on its receptors to activate intracellular signaling cascades such as those mediated by PI3K/Akt. This activation can lead to downstream effects that promote the functional activity of 1190002F15Rik, assuming 1190002F15Rik is part of the PI3K/Akt pathway or is modulated by downstream effects of this pathway. | ||||||
PMA | 16561-29-8 | sc-3576 sc-3576A sc-3576B sc-3576C sc-3576D | 1 mg 5 mg 10 mg 25 mg 100 mg | $41.00 $132.00 $214.00 $500.00 $948.00 | 119 | |
PMA is a diacylglycerol analog which activates protein kinase C (PKC). PKC activation can lead to altered phosphorylation states of proteins, potentially including those that interact directly or indirectly with 1190002F15Rik, resulting in enhanced functional activity of 1190002F15Rik. | ||||||
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $123.00 $400.00 | 148 | |
LY294002 is an inhibitor of PI3K, leading to altered signaling downstream of PI3K. If 1190002F15Rik is negatively regulated by the PI3K pathway, inhibition by LY294002 could relieve this negative regulation, thereby enhancing the activity of 1190002F15Rik. | ||||||
SB 203580 | 152121-47-6 | sc-3533 sc-3533A | 1 mg 5 mg | $90.00 $349.00 | 284 | |
SB203580 is an inhibitor of p38 MAPK. If 1190002F15Rik functions are positively regulated when p38 MAPK is inhibited, then SB203580 can enhance the activity of 1190002F15Rik by shifting the signaling dynamics in favor of the pathways that activate 1190002F15Rik. | ||||||
A23187 | 52665-69-7 | sc-3591 sc-3591B sc-3591A sc-3591C | 1 mg 5 mg 10 mg 25 mg | $55.00 $131.00 $203.00 $317.00 | 23 | |
A23187 is an ionophore that increases intracellular calcium levels. Elevated calcium can activate various calcium-dependent signaling mechanisms, including calmodulin-dependent kinases, which could enhance the functional activity of 1190002F15Rik if it is modulated by calcium-mediated signaling. | ||||||
Genistein | 446-72-0 | sc-3515 sc-3515A sc-3515B sc-3515C sc-3515D sc-3515E sc-3515F | 100 mg 500 mg 1 g 5 g 10 g 25 g 100 g | $45.00 $164.00 $200.00 $402.00 $575.00 $981.00 $2031.00 | 46 | |
Genistein is a tyrosine kinase inhibitor that may enhance the activity of 1190002F15Rik if the protein is negatively regulated by tyrosine kinase activity. By reducing competitive phosphorylation, genistein could shift the balance to favor the functional activity of 1190002F15Rik. | ||||||
Staurosporine | 62996-74-1 | sc-3510 sc-3510A sc-3510B | 100 µg 1 mg 5 mg | $82.00 $153.00 $396.00 | 113 | |
Staurosporine is a broad-spectrum protein kinase inhibitor. While it is not selective, if specific kinases negatively regulate 1190002F15Rik, staurosporine could lift this inhibition and thereby enhance the functional activity of 1190002F15Rik. | ||||||
Wortmannin | 19545-26-7 | sc-3505 sc-3505A sc-3505B | 1 mg 5 mg 20 mg | $67.00 $223.00 $425.00 | 97 | |
Wortmannin is another potent PI3K inhibitor. Similar to LY294002, by inhibiting PI3K, Wortmannin could alleviate negative regulation on 1190002F15Rik, assuming that PI3K pathway activity has a suppressive effect on 1190002F15Rik, thus enhancing its activity. | ||||||